HIV/AIDS Topics IDWeek 2015 Features HIV and Hepatitis C Prevention, Treatment, and Cure Research
- Details
- Category: HIV Treatment
- Published on Wednesday, 07 October 2015 00:00
- Written by HIVandHepatitis.com
Immediate antiretroviral therapy is the big HIV news of the year and interferon-free therapy has transformed the treatment of hepatitis C despite its high cost, experts said during an overview of "What's Hot" in the field, presented at the IDWeek 2015 conference taking place this week in San Diego. Participants also heard a keynote talk by Ian Crozier, a doctor who survived Ebola virus disease.
Recent Infection and Treatment Interruptions Are Key Periods for HIV Transmission
- Details
- Category: Treatment as Prevention
- Published on Tuesday, 06 October 2015 00:00
- Written by Michael Carter
A large proportion of HIV transmissions occur during recent infection or antiretroviral therapy interruptions, Swiss investigators report in the September 19 advance edition of Clinical Infectious Diseases. Overall, 44% of transmissions were associated with recent infection and 14% could be attributed to treatment interruptions. The authors believe these findings represent a major challenge for treatment as prevention (TasP) strategies.
Coverage of IDWeek 2015
- Details
- Category: HIV Treatment
- Published on Tuesday, 06 October 2015 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of IDWeek 2015, October 7-11 in San Diego.
Conference highlights include new HIV therapies and treatment strategies, HIV and hepatitis C continuums of care, and comorbidities among people with HIV and HIV/HCV coinfection, as well as news about antibiotic stewardship and other infectious diseases including Ebola virus.
Full listing of coverage by topic
10/9/15
Coverage of 2015 Interscience Conference on Antimicrobial Agents and Chemotherapy
- Details
- Category: HIV Treatment
- Published on Tuesday, 06 October 2015 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the 55th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, September 17-21, 2015.
Highlights of this year's conference include experimental antiretroviral drugs and treatment strategies, HIV prevention, and comorbidities among people with HIV and HIV/HCV coinfection.
10/6/15
Vaginal Infections May Help Explain Link Between Hormonal Contraception and Increased HIV Risk
- Details
- Category: HIV Sexual Transmission
- Published on Thursday, 01 October 2015 00:00
- Written by American Society for Microbiology
Hormones may alter genital tract immunity in a way that makes women more prone to bacterial and viral infections, while disturbances in natural vaginal microbes may also contribute to the association seen in some studies between use of hormonal contraceptives such as Dep-Provera and susceptibility to HIV infection, according to a laboratory study published in the online journal mBio.
Web Design and Development by